These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
328 related articles for article (PubMed ID: 7610682)
1. [Multiple sclerosis--current status of therapy]. Reichel D; Kölmel HW Z Arztl Fortbild (Jena); 1995 May; 89(2):151-8. PubMed ID: 7610682 [TBL] [Abstract][Full Text] [Related]
2. Combination therapy for the treatment of multiple sclerosis: challenges and opportunities. Stuart WH Curr Med Res Opin; 2007 Jun; 23(6):1199-208. PubMed ID: 17559719 [TBL] [Abstract][Full Text] [Related]
3. [Cyclophosphamide in therapy of chronic progressive multiple sclerosis. Critical analysis of current studies]. Pette M; Hartung HP; Toyka KV Nervenarzt; 1994 Apr; 65(4):271-4. PubMed ID: 8015636 [No Abstract] [Full Text] [Related]
4. [Immunosuppressive treatment in multiple sclerosis]. Vermeulen M; Zegerius L; van Crevel H Ned Tijdschr Geneeskd; 1987 Jan; 131(3):93-6. PubMed ID: 3821989 [No Abstract] [Full Text] [Related]
6. Current disease-modifying therapies in multiple sclerosis. Kieseier BC; Hartung HP Semin Neurol; 2003 Jun; 23(2):133-46. PubMed ID: 12894379 [TBL] [Abstract][Full Text] [Related]
7. Proceedings: Intensive immunosuppression in multiple sclerosis. Lance EM; Abbosh J; Kremer M; Jones V; Knight S; Medawar P Neurology; 1975 May; 25(5):491. PubMed ID: 1169713 [No Abstract] [Full Text] [Related]
8. [Cyclophosphamide in the therapy of multiple sclerosis]. Salvatores U; Majeron M; Mascetti A Riv Sper Freniatr Med Leg Alien Ment; 1972 Feb; 96(1):163-84. PubMed ID: 4337775 [No Abstract] [Full Text] [Related]
9. [Long-term therapeutic trials and multiple sclerosis: a wager?]. Confavreux C Rev Neurol (Paris); 1983; 139(6-7):431-7. PubMed ID: 6412341 [No Abstract] [Full Text] [Related]
12. [Immunosuppressive therapy of multiple sclerosis using cyclophosphamide with few side effects]. Kornhuber HH; Mauch E Dtsch Med Wochenschr; 1986 Nov; 111(46):1778. PubMed ID: 3780443 [No Abstract] [Full Text] [Related]
13. [Immunosuppressive treatment in neurological disorders]. Aarli JA Tidsskr Nor Laegeforen; 1973 Jun; 93(18):1395-7. PubMed ID: 4356438 [No Abstract] [Full Text] [Related]
14. [Guidelines for drug treatment of multiple sclerosis]. Kollegger H; Vass K; Marschall I; Koch G; Deecke L Wien Klin Wochenschr; 1993; 105(16):443-52. PubMed ID: 7692677 [TBL] [Abstract][Full Text] [Related]
15. [New disease-modifying and symptomatic therapies for multiple sclerosis]. Weise G; Buttmann M MMW Fortschr Med; 2012 Apr; 154(7):64-6. PubMed ID: 22558878 [No Abstract] [Full Text] [Related]
16. [Treatment of multiple sclerosis. The present and the future. Study Group on Diagnosis and Therapy of Multiple Sclerosis]. Cazzato G; Antonello RM; Zorzon M; Torre P; Zivadinov R; Moretti R; Bragadin LM; De Masi R; Nasuelli D Recenti Prog Med; 1999 Oct; 90(10):538-44. PubMed ID: 10592740 [TBL] [Abstract][Full Text] [Related]
17. [Current methods of the multiple sclerosis treatment]. Kovalenko PA; Shamanskiĭ SV; Baziĭ NI Voen Med Zh; 2001 Oct; 322(10):45-52. PubMed ID: 11764483 [No Abstract] [Full Text] [Related]
18. Immunosuppressive treatment of multiple sclerosis. Carter JL; Rodriguez M Mayo Clin Proc; 1989 Jun; 64(6):664-9. PubMed ID: 2473360 [TBL] [Abstract][Full Text] [Related]
19. [Immunosuppressive medication in multiple sclerosis]. García Merino JA Rev Neurol; 2002 Dec 16-31; 35(12):1154-8. PubMed ID: 12497298 [TBL] [Abstract][Full Text] [Related]